Encompass Health Co. (NYSE:EHC) Shares Sold by OLD National Bancorp IN

OLD National Bancorp IN cut its holdings in Encompass Health Co. (NYSE:EHC) by 79.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 8,000 shares of the company’s stock after selling 31,020 shares during the period. OLD National Bancorp IN’s holdings in Encompass Health were worth $534,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. McGlone Suttner Wealth Management Inc. acquired a new position in shares of Encompass Health in the 4th quarter valued at about $30,000. C M Bidwell & Associates Ltd. acquired a new position in shares of Encompass Health in the 3rd quarter valued at about $35,000. Harvest Fund Management Co. Ltd acquired a new position in shares of Encompass Health in the 3rd quarter valued at about $109,000. Acadian Asset Management LLC acquired a new position in shares of Encompass Health in the 3rd quarter valued at about $111,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Encompass Health by 14.7% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company’s stock valued at $182,000 after buying an additional 347 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

EHC has been the topic of several recent research reports. Barclays lifted their price objective on shares of Encompass Health from $95.00 to $101.00 and gave the company an “overweight” rating in a research report on Thursday, March 28th. Royal Bank of Canada reiterated an “outperform” rating and issued a $83.00 price objective on shares of Encompass Health in a research report on Friday, February 9th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Mizuho lifted their price objective on shares of Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, February 9th. Finally, Truist Financial lifted their price objective on shares of Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research report on Friday, February 9th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $83.22.

Encompass Health Stock Up 0.3 %

EHC stock opened at $82.72 on Thursday. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $83.73. The company has a market capitalization of $8.28 billion, a price-to-earnings ratio of 23.84, a price-to-earnings-growth ratio of 1.53 and a beta of 0.94. The firm’s 50-day moving average is $77.89 and its two-hundred day moving average is $70.67. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, February 7th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.12. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The business had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. On average, analysts forecast that Encompass Health Co. will post 3.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. The ex-dividend date was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is currently 17.29%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.